ScholarIQanswers from OpenAlex

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis

PaperCitations, authors & open-access status

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis have?

ScholarIQcitation count

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis has 179 citations in the OpenAlex counts ScholarIQ stores.

When was miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis published?

ScholarIQyear

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis has 2018 year in the ScholarIQ index.

What is the open-access status of miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis?

ScholarIQoa status

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis has gold oa status in the ScholarIQ index.

What is the DOI of miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis?

ScholarIQdoi

The DOI for miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis is on the source record.

What is the PMID of miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis?

ScholarIQpmid

The PMID for miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis is on the source record.

What is the OpenAlex record for miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis?

ScholarIQopenalex

The OpenAlex for miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial